scholarly journals Using machine learning to estimate the effect of racial segregation on COVID-19 mortality in the United States

2021 ◽  
Vol 118 (7) ◽  
pp. e2015577118
Author(s):  
Gerard Torrats-Espinosa

This study examines the role that racial residential segregation has played in shaping the spread of COVID-19 in the United States as of September 30, 2020. The analysis focuses on the effects of racial residential segregation on mortality and infection rates for the overall population and on racial and ethnic mortality gaps. To account for potential confounding, I assemble a dataset that includes 50 county-level factors that are potentially related to residential segregation and COVID-19 infection and mortality rates. These factors are grouped into eight categories: demographics, density and potential for public interaction, social capital, health risk factors, capacity of the health care system, air pollution, employment in essential businesses, and political views. I use double-lasso regression, a machine learning method for model selection and inference, to select the most important controls in a statistically principled manner. Counties that are 1 SD above the racial segregation mean have experienced mortality and infection rates that are 8% and 5% higher than the mean. These differences represent an average of four additional deaths and 105 additional infections for each 100,000 residents in the county. The analysis of mortality gaps shows that, in counties that are 1 SD above the Black–White segregation mean, the Black mortality rate is 8% higher than the White mortality rate. Sensitivity analyses show that an unmeasured confounder that would overturn these findings is outside the range of plausible covariates.

1966 ◽  
Vol 27 (1) ◽  
pp. 98
Author(s):  
Stephen H. K. Yeh ◽  
Karl E. Taeuber ◽  
Alma F. Taeuber

2018 ◽  
Vol 51 ◽  
pp. 208-216 ◽  
Author(s):  
Andrew D. Williams ◽  
Maeve Wallace ◽  
Carrie Nobles ◽  
Pauline Mendola

2012 ◽  
Vol 102 (7) ◽  
pp. 1370-1377 ◽  
Author(s):  
Katie B Biello ◽  
Trace Kershaw ◽  
Robert Nelson ◽  
Matthew Hogben ◽  
Jeannette Ickovics ◽  
...  

1975 ◽  
Vol 8 (2) ◽  
pp. 125-142 ◽  
Author(s):  
Annemette Sørensen ◽  
Karl E. Taeuber ◽  
Leslie J. Hollingsworth

2021 ◽  
Vol 14 (5) ◽  
pp. 472
Author(s):  
Tyler C. Beck ◽  
Kyle R. Beck ◽  
Jordan Morningstar ◽  
Menny M. Benjamin ◽  
Russell A. Norris

Roughly 2.8% of annual hospitalizations are a result of adverse drug interactions in the United States, representing more than 245,000 hospitalizations. Drug–drug interactions commonly arise from major cytochrome P450 (CYP) inhibition. Various approaches are routinely employed in order to reduce the incidence of adverse interactions, such as altering drug dosing schemes and/or minimizing the number of drugs prescribed; however, often, a reduction in the number of medications cannot be achieved without impacting therapeutic outcomes. Nearly 80% of drugs fail in development due to pharmacokinetic issues, outlining the importance of examining cytochrome interactions during preclinical drug design. In this review, we examined the physiochemical and structural properties of small molecule inhibitors of CYPs 3A4, 2D6, 2C19, 2C9, and 1A2. Although CYP inhibitors tend to have distinct physiochemical properties and structural features, these descriptors alone are insufficient to predict major cytochrome inhibition probability and affinity. Machine learning based in silico approaches may be employed as a more robust and accurate way of predicting CYP inhibition. These various approaches are highlighted in the review.


2021 ◽  
pp. 1-4
Author(s):  
Mathieu D'Aquin ◽  
Stefan Dietze

The 29th ACM International Conference on Information and Knowledge Management (CIKM) was held online from the 19 th to the 23 rd of October 2020. CIKM is an annual computer science conference, focused on research at the intersection of information retrieval, machine learning, databases as well as semantic and knowledge-based technologies. Since it was first held in the United States in 1992, 28 conferences have been hosted in 9 countries around the world.


1966 ◽  
Vol 4 (4) ◽  
pp. 13-13

Last month the US Food and Drug Administration required American manufacturers of long-acting sulphonamides (sulphamethoxypyridazine, Lederkyn - Lederle and Midicel - PD; sulphadimethoxine - Madribon - Roche) to warn prescribers that in rare cases the Stevens-Johnson syndrome may develop as a severe and sometimes fatal side effect. This syndrome is a type of erythema multiforme in which large blisters appear on the skin and especially on the mucous membranes. The manufacturers were also to advise doctors ‘to consider prescribing short-acting sulphonamides first because they are effective for most of the same conditions’. The three drug firms concerned accordingly sent a joint warning letter to all doctors, pointing out that the Stevens-Johnson syndrome is a serious complication with a mortality rate of about 25%. So far 116 cases of this syndrome have been reported in association with the use of long-acting sulphonamides, most of them in the United States. Almost two thirds of the patients were children.


Sign in / Sign up

Export Citation Format

Share Document